Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 30

1.

Treatment compliance and noncompliance in psychoses.

Rao KN, George J, Sudarshan CY, Begum S.

Indian J Psychiatry. 2017 Jan-Mar;59(1):69-76. doi: 10.4103/psychiatry.IndianJPsychiatry_24_17.

2.

Weighing the evidence for harm from long-term treatment with antipsychotic medications: A systematic review.

Sohler N, Adams BG, Barnes DM, Cohen GH, Prins SJ, Schwartz S.

Am J Orthopsychiatry. 2016;86(5):477-85. doi: 10.1037/ort0000106. Epub 2015 Dec 14.

3.

Antipsychotic Maintenance Treatment: Time to Rethink?

Moncrieff J.

PLoS Med. 2015 Aug 4;12(8):e1001861. doi: 10.1371/journal.pmed.1001861. eCollection 2015 Aug.

4.

High relapse rate and poor medication adherence in the Chinese population with schizophrenia: results from an observational survey in the People's Republic of China.

Xiao J, Mi W, Li L, Shi Y, Zhang H.

Neuropsychiatr Dis Treat. 2015 May 8;11:1161-7. doi: 10.2147/NDT.S72367. eCollection 2015.

5.

Development and application of an aggregate adherence metric derived from population pharmacokinetics to inform clinical trial enrichment.

Knights J, Rohatagi S.

J Pharmacokinet Pharmacodyn. 2015 Jun;42(3):263-73. doi: 10.1007/s10928-015-9414-4. Epub 2015 Mar 29.

6.

Antipsychotic drugs in pregnancy: a review of their maternal and fetal effects.

Galbally M, Snellen M, Power J.

Ther Adv Drug Saf. 2014 Apr;5(2):100-9. doi: 10.1177/2042098614522682. Review.

7.

Tardive dyskinesia in patients treated with atypical antipsychotics: case series and brief review of etiologic and treatment considerations.

Kim J, Macmaster E, Schwartz TL.

Drugs Context. 2014 Apr 9;3:212259. doi: 10.7573/dic.212259. eCollection 2014.

8.
9.

Perspectives on reasons for non-adherence to medication in persons with schizophrenia in Ethiopia: a qualitative study of patients, caregivers and health workers.

Teferra S, Hanlon C, Beyero T, Jacobsson L, Shibre T.

BMC Psychiatry. 2013 Jun 17;13:168. doi: 10.1186/1471-244X-13-168.

10.

Does long-term treatment of schizophrenia with antipsychotic medications facilitate recovery?

Harrow M, Jobe TH.

Schizophr Bull. 2013 Sep;39(5):962-5. doi: 10.1093/schbul/sbt034. Epub 2013 Mar 19. Review.

11.

The nature of relapse in schizophrenia.

Emsley R, Chiliza B, Asmal L, Harvey BH.

BMC Psychiatry. 2013 Feb 8;13:50. doi: 10.1186/1471-244X-13-50. Review.

12.

Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia.

Ho BC, Andreasen NC, Ziebell S, Pierson R, Magnotta V.

Arch Gen Psychiatry. 2011 Feb;68(2):128-37. doi: 10.1001/archgenpsychiatry.2010.199.

13.

Movement disorders induced by antipsychotic drugs: implications of the CATIE schizophrenia trial.

Caroff SN, Hurford I, Lybrand J, Campbell EC.

Neurol Clin. 2011 Feb;29(1):127-48, viii. doi: 10.1016/j.ncl.2010.10.002.

14.

Maintenance treatment with quetiapine versus discontinuation after one year of treatment in patients with remitted first episode psychosis: randomised controlled trial.

Chen EY, Hui CL, Lam MM, Chiu CP, Law CW, Chung DW, Tso S, Pang EP, Chan KT, Wong YC, Mo FY, Chan KP, Yao TJ, Hung SF, Honer WG.

BMJ. 2010 Aug 19;341:c4024. doi: 10.1136/bmj.c4024.

15.

Prevention of schizophrenia relapse with extended release quetiapine fumarate dosed once daily: a randomized, placebo-controlled trial in clinically stable patients.

Peuskens J, Trivedi J, Malyarov S, Brecher M, Svensson O, Miller F, Persson I, Meulien D.

Psychiatry (Edgmont). 2007 Nov;4(11):34-50.

16.

Psychotropic medication nonadherence among United States Latinos: a comprehensive literature review.

Lanouette NM, Folsom DP, Sciolla A, Jeste DV.

Psychiatr Serv. 2009 Feb;60(2):157-74. doi: 10.1176/appi.ps.60.2.157. Review.

17.

Clinical recovery in first-episode psychosis.

Wunderink L, Sytema S, Nienhuis FJ, Wiersma D.

Schizophr Bull. 2009 Mar;35(2):362-9. doi: 10.1093/schbul/sbn143. Epub 2008 Nov 5.

18.

The Sertindole Safety Survey: a retrospective analysis under a named patient use programme in Europe.

Lançon C, Toumi M, Sapin C, Hansen K.

BMC Psychiatry. 2008 Jul 18;8:57. doi: 10.1186/1471-244X-8-57.

19.

The Amsterdam Studies of Acute Psychiatry I (ASAP-I); a prospective cohort study of determinants and outcome of coercive versus voluntary treatment interventions in a metropolitan area.

van der Post L, Schoevers R, Koppelmans V, Visch I, Bernardt C, Mulder N, Beekman A, de Haan L, Dekker J.

BMC Psychiatry. 2008 May 14;8:35. doi: 10.1186/1471-244X-8-35.

20.

Evaluation of patients on sertindole treatment after failure of other antipsychotics: a retrospective analysis.

Azorin JM, Murteira S, Hansen K, Toumi M.

BMC Psychiatry. 2008 Mar 14;8:16. doi: 10.1186/1471-244X-8-16.

Supplemental Content

Support Center